Functionalizing novel modulators of lung cancer
Lung cancer is the leading cause of cancer mortality globally, with lung adenocarcinoma being the most prevalent subtype. The discovery of driver mutations has paved the way for the use of targeted therapy, notably EGFR inhibitors, in the management of advanced disease. However, the effectiveness of...
Saved in:
| 主要作者: | |
|---|---|
| 其他作者: | |
| 格式: | Thesis-Doctor of Philosophy |
| 語言: | English |
| 出版: |
Nanyang Technological University
2022
|
| 主題: | |
| 在線閱讀: | https://hdl.handle.net/10356/160418 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
| 機構: | Nanyang Technological University |
| 語言: | English |